A robust microsatellite instability detection model for unpaired colorectal cancer tissue samples

Abstract Background: Microsatellite instability (MSI) is a key biomarker for cancer immunotherapy and prognosis. Integration of MSI testing into a next-generation-sequencing (NGS) panel could save tissue sample, reduce turn-around time and cost, and provide MSI status and comprehensive genomic profiling in single test. We aimed to develop an MSI calling model to detect MSI status along with the NGS panel-based profiling test using tumor-only samples. Methods: From January 2019 to December 2020, a total of 174 colorectal cancer (CRC) patients were enrolled, including 31 MSI-high (MSI-H) and 143 microsatellite stability (MSS) cases. Among them, 56 paired tumor and normal samples (10 MSI-H and 46 MSS) were used for modeling, and another 118 tumor-only samples were used for validation. MSI polymerase chain reaction (MSI-PCR) was performed as the gold standard. A baseline was built for the selected microsatellite loci using the NGS data of 56 normal blood samples. An MSI detection model was constructed by analyzing the NGS data of tissue samples. The performance of the model was compared with the results of MSI-PCR. Results: We first intersected the target genomic regions of the NGS panels used in this study to select common microsatellite loci. A total of 42 loci including 23 mononucleotide repeat sites and 19 longer repeat sites were candidates for modeling. As mononucleotide repeat sites are more sensitive and specific for detecting MSI status than sites with longer length motif and the mononucleotide repeat sites performed even better than the total sites, a model containing 23 mononucleotide repeat sites was constructed and named Colorectal Cancer Microsatellite Instability test (CRC-MSI). The model achieved 100% sensitivity and 100% specificity when compared with MSI-PCR in both training and validation sets. Furthermore, the CRC-MSI model was robust with the tumor content as low as 6%. In addition, 8 out of 10 MSI-H samples showed alternations in the four mismatch repair genes (MLH1, MSH2, MSH6, and PMS2). Conclusion: MSI status can be accurately determined along the targeted NGS panels using only tumor samples. The performance of mononucleotide repeat sites surpasses loci with longer repeat motif in MSI calling.

[1]  Chunze Zhang,et al.  A novel NGS-based microsatellite instability (MSI) status classifier with 9 loci for colorectal cancer patients , 2020, Journal of Translational Medicine.

[2]  Jianyong Sun,et al.  MSIsensor-pro: Fast, Accurate, and Matched-normal-sample-free Detection of Microsatellite Instability , 2020, Genom. Proteom. Bioinform..

[3]  M. Mansukhani,et al.  Microsatellite instability detection using a large next-generation sequencing cancer panel across diverse tumour types , 2019, Journal of Clinical Pathology.

[4]  A. Scarpa,et al.  ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  Tae Won Kim,et al.  Mutation Burden and I Index for Detection of Microsatellite Instability in Colorectal Cancer by Targeted Next-Generation Sequencing. , 2019, The Journal of molecular diagnostics : JMD.

[6]  J. Marshall,et al.  Microsatellite instability status determined by next‐generation sequencing and compared with PD‐L1 and tumor mutational burden in 11,348 patients , 2018, Cancer medicine.

[7]  Jinghong Xu,et al.  A Novel and Reliable Method to Detect Microsatellite Instability in Colorectal Cancer by Next-Generation Sequencing. , 2017, The Journal of molecular diagnostics : JMD.

[8]  Russell Bonneville,et al.  Landscape of Microsatellite Instability Across 39 Cancer Types. , 2017, JCO precision oncology.

[9]  Ludmila V. Danilova,et al.  Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade , 2017, Science.

[10]  Levi Garraway,et al.  Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden , 2017, Genome Medicine.

[11]  Russell Bonneville,et al.  Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS , 2016, Oncotarget.

[12]  X. Qian,et al.  Prediction of biological behavior and prognosis of colorectal cancer patients by tumor MSI/MMR in the Chinese population , 2016, OncoTargets and therapy.

[13]  Jay Shendure,et al.  Classification and characterization of microsatellite instability across 18 cancer types , 2016, Nature Medicine.

[14]  J. Skibber,et al.  DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  P. Wei,et al.  Immunohistochemistry and microsatellite instability analysis in molecular subtyping of colorectal carcinoma based on mismatch repair competency. , 2015, International journal of clinical and experimental medicine.

[16]  Sheena M. Scroggins,et al.  MSIplus for Integrated Colorectal Cancer Molecular Testing by Next-Generation Sequencing. , 2015, The Journal of molecular diagnostics : JMD.

[17]  Bert Vogelstein,et al.  PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. , 2015, The New England journal of medicine.

[18]  Colin C Pritchard,et al.  Microsatellite instability detection by next generation sequencing. , 2014, Clinical chemistry.

[19]  Kai Ye,et al.  MSIsensor: microsatellite instability detection using paired tumor-normal sequence data , 2014, Bioinform..

[20]  Heng Li.  Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM , 2013, 1303.3997.

[21]  Christopher A. Miller,et al.  VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.

[22]  M. Pino,et al.  Microsatellite instability in the management of colorectal cancer , 2011, Expert review of gastroenterology & hepatology.

[23]  Mari Mino-Kenudson,et al.  Deficient DNA mismatch repair is common in Lynch syndrome-associated colorectal adenomas. , 2009, The Journal of molecular diagnostics : JMD.

[24]  S. Berndt,et al.  Mismatch repair polymorphisms and the risk of colorectal cancer , 2007, International journal of cancer.

[25]  A. Duval,et al.  Quasimonomorphic Mononucleotide Repeats for High-Level Microsatellite Instability Analysis , 2004, Disease markers.

[26]  A. Duval,et al.  Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. , 2002, Gastroenterology.

[27]  B. Haas,et al.  A clustering method for repeat analysis in DNA sequences , 2001, Genome Biology.

[28]  J. Herman,et al.  Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[29]  [Consensus on the detection of microsatellite instability in colorectal cancer and other related solid tumors in China]. , 2019, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[30]  Nivolumab plus Ipilimumab Achieves Responses in dMMR/MSI-H Tumors. , 2018, Cancer discovery.

[31]  Suet Yi Leung,et al.  Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1 , 2009, Nature Genetics.

[32]  P. Peltomäki.  Lynch Syndrome Genes , 2004, Familial Cancer.